{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:38:14Z","timestamp":1791999494328,"version":"4.4.0"},"reference-count":210,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Peyronie\u2019s disease (PD) is a benign condition caused by plaque formation on the tunica albuginea of the penis. It is associated with penile pain, curvature, and shortening, and contributes to erectile dysfunction, which worsens patient quality of life. In recent years, research into understanding of the detailed mechanisms and risk factors involved in the development of PD has been increasing. In this review, the pathological mechanisms and several closely related signaling pathways, including TGF-\u03b2, WNT\/\u03b2-catenin, Hedgehog, YAP\/TAZ, MAPK, ROCK, and PI3K\/AKT, are described. Findings regarding cross-talk among these pathways are then discussed to elucidate the complicated cascade behind tunica albuginea fibrosis. Finally, various risk factors including the genes involved in the development of PD are presented and their association with the disease summarized. The purpose of this review is to provide a better understanding regarding the involvement of risk factors in the molecular mechanisms associated with PD pathogenesis, as well as to provide insight into disease prevention and novel therapeutic interventions.<\/jats:p>","DOI":"10.3390\/ijms241210133","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T01:32:57Z","timestamp":1686792777000},"page":"10133","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie\u2019s Disease"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2919-0058","authenticated-orcid":false,"given":"Yozo","family":"Mitsui","sequence":"first","affiliation":[{"name":"Department of Urology, Toho University Faculty of Medicine, Tokyo 143-8540, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumito","family":"Yamabe","sequence":"additional","affiliation":[{"name":"Department of Urology, Toho University Faculty of Medicine, Tokyo 143-8540, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Hori","sequence":"additional","affiliation":[{"name":"Department of Urology, Toho University Faculty of Medicine, Tokyo 143-8540, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Uetani","sequence":"additional","affiliation":[{"name":"Department of Urology, Toho University Faculty of Medicine, Tokyo 143-8540, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1381-1665","authenticated-orcid":false,"given":"Hideyuki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Urology, Toho University Faculty of Medicine, Tokyo 143-8540, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2798-4567","authenticated-orcid":false,"given":"Koichi","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Urology, Toho University Faculty of Medicine, Tokyo 143-8540, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Urology, Toho University Faculty of Medicine, Tokyo 143-8540, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5534\/wjmh.200065","article-title":"The natural history of Peyronie\u2019s disease","volume":"39","author":"Cito","year":"2021","journal-title":"World J. Mens Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0022-5347(05)64578-8","article-title":"A retrospective review of 307 men with Peyronie\u2019s disease","volume":"168","author":"Kadioglu","year":"2002","journal-title":"J. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie\u2019s disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/bju.12346","article-title":"Deformity stabilization and improvement in men with untreated Peyronie\u2019s disease","volume":"113","author":"Berookhim","year":"2014","journal-title":"BJU. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1743-6109.2012.02999.x","article-title":"Psychological impact of Peyronie\u2019s disease: A review","volume":"10","author":"Nelson","year":"2013","journal-title":"J. Sex. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.21037\/tau.2016.05.14","article-title":"Psychological aspects of Peyronie\u2019s disease","volume":"5","author":"Terrier","year":"2016","journal-title":"Transl. Androl. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/j.1743-6109.2008.00895.x","article-title":"The chronology of depression and distress in men with Peyronie\u2019s disease","volume":"5","author":"Nelson","year":"2008","journal-title":"J. Sex. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/JU.0000000000001426","article-title":"Mental disorders in Peyronie\u2019s disease: A Swedish cohort study of 3.5 million men","volume":"205","author":"Henningsohn","year":"2021","journal-title":"J. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/andr.13352","article-title":"The symptomatic burden of Peyronie\u2019s disease at presentation according to patient age: A critical analysis of the Peyronie\u2019s disease questionnaire (PDQ) domains","volume":"11","author":"Cilio","year":"2023","journal-title":"Andrology"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Spirito, L., Manfredi, C., La Rocca, R., Napolitano, L., Di Girolamo, A., Capece, M., Trama, F., Sciorio, C., Sokolakis, I., and Creta, M. (2022). Daily low dose tadalafil may reduce the penile curvature progression rate in patients with acute Peyronie\u2019s disease: A retrospective comparative analysis. Int. J. Impot. Res.","DOI":"10.1038\/s41443-022-00651-8"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Capece, M., Arcaniolo, D., Manfredi, C., Palmieri, A., De Sio, M., Verze, P., Fusco, F., Longo, N., and Mirone, V. (2020). Second cycle of intralesional Collagenase Clostridium histolyticum for Peyronie\u2019s disease using the modified shortened protocol: Results from a retrospective analysis. Andrologia, 52.","DOI":"10.1111\/and.13527"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/andr.13240","article-title":"Impact of extracorporeal shockwave therapy for erectile dysfunction and Peyronie\u2019s disease on reproductive and hormonal testicular function","volume":"10","author":"Manfredi","year":"2022","journal-title":"Andrology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jsxm.2021.06.012","article-title":"Extracorporeal shockwave therapy in Peyronie\u2019s disease: Systematic review and meta-analysis","volume":"18","author":"Bakr","year":"2021","journal-title":"J. Sex. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.sxmr.2022.01.001","article-title":"Penile modeling in Peyronie\u2019s disease: A systematic review of the literature","volume":"10","author":"Krishnappa","year":"2022","journal-title":"Sex. Med. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.23736\/S2724-6051.20.03890-4","article-title":"Penile prosthesis implant in the management of Peyronies\u2019 disease","volume":"73","author":"Verze","year":"2021","journal-title":"Minerva. Urol. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.jsxm.2020.07.079","article-title":"Multicenter prospective study of grafting with collagen fleece TachoSil in patients with Peyronie\u2019s disease","volume":"17","author":"Manfredi","year":"2020","journal-title":"J. Sex. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Gelbard, M.K., and Rosenbloom, J. (2020). Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie\u2019s disease, Dupuytren disease and diabetes. Endocrinol. Diabetes. Metab., 4.","DOI":"10.1002\/edm2.195"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.esxm.2019.11.002","article-title":"Prevalence, risk factors, and erectile dysfunction associated with Peyronie\u2019s disease among men seeking urological care","volume":"8","author":"Segundo","year":"2020","journal-title":"Sex. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.sxmr.2015.10.002","article-title":"The genetic basis of Peyronie disease: A review","volume":"4","author":"Herati","year":"2016","journal-title":"Sex. Med. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.sxmr.2019.02.004","article-title":"Pathophysiology and future therapeutic perspectives for resolving fibrosis in Peyronie\u2019s disease","volume":"7","author":"Milenkovic","year":"2019","journal-title":"Sex. Med. Rev."},{"key":"ref_21","first-page":"165","article-title":"New insights into the pathogenesis of Peyronie\u2019s disease: A narrative review","volume":"6","author":"Krakhotkin","year":"2020","journal-title":"Chronic. Dis. Transl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.ijir.3900727","article-title":"Prevalence of Peyronie\u2019s disease in men over 50 years old in southern Brazil","volume":"13","author":"Rhoden","year":"2001","journal-title":"Int. J. Impot. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1743-6109.2009.01655.x","article-title":"Peyronie\u2019s disease following radical prostatectomy: Incidence and predictors","volume":"7","author":"Tal","year":"2010","journal-title":"J. Sex. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1111\/j.1743-6109.2012.02868.x","article-title":"The prevalence of Peyronie\u2019s disease in Japan: A study in men undergoing maintenance hemodialysis and routine health checks","volume":"9","author":"Shiraishi","year":"2012","journal-title":"J. Sex. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jsxm.2016.04.062","article-title":"Evidence-based management guidelines on Peyronie\u2019s disease","volume":"13","author":"Chung","year":"2016","journal-title":"J. Sex. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Capoccia, E., and Levine, L.A. (2018). Contemporary review of Peyronie\u2019s disease treatment. Curr. Urol. Rep., 19.","DOI":"10.1007\/s11934-018-0800-5"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/bju.14410","article-title":"Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie\u2019s disease: Development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study","volume":"122","author":"Cocci","year":"2018","journal-title":"BJU Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-5347(01)65361-8","article-title":"Proposal: Trauma as the cause of the Peyronie\u2019s lesion","volume":"157","author":"Devine","year":"1997","journal-title":"J. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000475601","article-title":"Repeated micro-trauma of the penile tunica albuginea: A new animal model of Peyronie\u2019s disease","volume":"100","author":"Jiang","year":"2018","journal-title":"Urol. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2014.02.015","article-title":"Cellular and molecular mechanisms in liver fibrogenesis","volume":"548","author":"Novo","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14728214.2019.1591370","article-title":"What role do pharmaceuticals play in the treatment of Peyronie\u2019s disease and is there a need for new emerging drugs?","volume":"24","author":"Milenkovic","year":"2019","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"L590","DOI":"10.1152\/ajplung.00221.2016","article-title":"Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis","volume":"311","author":"Ashley","year":"2016","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hou, J., Shi, J., Chen, L., Lv, Z., Chen, X., Cao, H., Xiang, Z., and Han, X. (2018). M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis. Cell Commun. Signal., 16.","DOI":"10.1186\/s12964-018-0300-8"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/cbin.11980","article-title":"Crosstalk between myofibroblasts and macrophages: A regulative factor of valvular fibrosis in calcific aortic valve disease","volume":"47","author":"Wu","year":"2023","journal-title":"Cell Biol. Int."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lis-L\u00f3pez, L., Bauset, C., Seco-Cervera, M., and Cos\u00edn-Roger, J. (2021). Is the macrophage phenotype determinant for fibrosis development?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121747"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0022-5347(01)65366-7","article-title":"Mechanisms by which fibrin and fibronectin appear in healing wounds: Implications for Peyronie\u2019s disease","volume":"157","year":"1997","journal-title":"J. Urol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Moretti, L., Stalfort, J., Barker, T.H., and Abebayehu, D. (2022). The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation. J. Biol. Chem., 298.","DOI":"10.1016\/j.jbc.2021.101530"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.4049\/jimmunol.148.8.2423","article-title":"Monocyte chemoattractant protein 1 regulates adhesion molecule expression and cytokine production in human monocytes","volume":"148","author":"Jiang","year":"1992","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Young, L.R., Gulleman, P.M., Short, C.W., Tanjore, H., Sherrill, T., Qi, A., McBride, A.P., Zaynagetdinov, R., Benjamin, J.T., and Lawson, W.E. (2016). Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome. JCI Insight, 1.","DOI":"10.1172\/jci.insight.88947"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0090-4295(01)01578-3","article-title":"Gene expression profiles in the Peyronie\u2019s disease plaque","volume":"59","author":"Magee","year":"2002","journal-title":"Urology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0006-291X(02)00765-9","article-title":"Upregulation of monocyte chemoattractant protein 1 and effects of transforming growth factor-beta 1 in Peyronie\u2019s disease","volume":"295","author":"Lin","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/intimm\/dxp017","article-title":"The roles of TLRs, RLRs and NLRs in pathogen recognition","volume":"21","author":"Kawai","year":"2009","journal-title":"Int. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: Therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev-pathol-020712-163930","article-title":"Host responses in tissue repair and fibrosis","volume":"8","author":"Duffield","year":"2013","journal-title":"Annu. Rev. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Rockey, D.C., Bell, P.D., and Hill, J.A. (2015). Fibrosis\u2014A common pathway to organ injury and failure. N. Engl. J. Med., 373.","DOI":"10.1056\/NEJMc1504848"},{"key":"ref_48","first-page":"6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"AMJ. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"R\u0151szer, T. (2015). Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediators. Inflamm., 2015.","DOI":"10.1155\/2015\/816460"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zielinski, C.E. (2023). T helper cell subsets: Diversification of the field. Eur. J. Immunol., 15.","DOI":"10.1002\/eji.202250218"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.joen.2022.04.010","article-title":"Effects of calcium hydroxide intracanal medications on T helper (Th1, Th2, Th9, Th17, and Tfh) and regulatory T (Treg) cell cytokines in apical periodontitis: A CONSORT RCT","volume":"48","author":"Teixeira","year":"2022","journal-title":"J. Endod."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-4939-7837-3_12","article-title":"Polarizing macrophages in vitro","volume":"1784","author":"Huang","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Yao, Y., Xu, X.H., and Jin, L. (2019). Macrophage polarization in physiological and pathological pregnancy. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00792"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Atri, C., Guerfali, F.Z., and Laouini, D. (2018). Role of human macrophage polarization in inflammation during infectious diseases. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061801"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/JLB.3RU1018-378RR","article-title":"M2b macrophage polarization and its roles in diseases","volume":"106","author":"Wang","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/JIR.S40673","article-title":"Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis","volume":"6","author":"Todd","year":"2013","journal-title":"J. Inflamm. Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Bosello, S., Angelucci, C., Lama, G., Alivernini, S., Proietti, G., Tolusso, B., Sica, G., Gremese, E., and Ferraccioli, G. (2018). Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. Arthritis Res. Ther., 20.","DOI":"10.1186\/s13075-018-1569-0"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Beesley, C.F., Goldman, N.R., Taher, T.E., Denton, C.P., Abraham, D.J., Mageed, R.A., and Ong, V.H. (2023). Dysregulated B cell function and disease pathogenesis in systemic sclerosis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.999008"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/art.40390","article-title":"Association of defective regulation of autoreactive interleukin-6-producing transitional B lymphocytes with disease in patients with systemic sclerosis","volume":"70","author":"Taher","year":"2018","journal-title":"Arthritis. Rheumatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2017.10.015","article-title":"Altered B lymphocyte homeostasis and functions in systemic sclerosis","volume":"17","author":"Forestier","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1172\/JCI125366","article-title":"Fra-2-expressing macrophages promote lung fibrosis in mice","volume":"129","author":"Ucero","year":"2019","journal-title":"J. Clin. Invest."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/CIRCRESAHA.115.303567","article-title":"Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction","volume":"115","author":"Heidt","year":"2014","journal-title":"Circ. Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Nakagawa, M., Karim, M.R., Izawa, T., Kuwamura, M., and Yamate, J. (2021). Immunophenotypical characterization of M1\/M2 macrophages and lymphocytes in cisplatin-induced rat progressive renal fibrosis. Cells, 10.","DOI":"10.3390\/cells10020257"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.kjms.2017.01.007","article-title":"Role of interleukin-6 and pentraxin 3 as an early marker in Peyronie\u2019s disease","volume":"33","author":"Atar","year":"2017","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1590\/S1677-55382008000400008","article-title":"Significant alterations of serum cytokine levels in patient with Peyronie\u2019s disease","volume":"34","author":"Zimmermann","year":"2008","journal-title":"Int. Braz. J. Urol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Cui, Y., Chen, L., Wang, X., Yu, L., and Wu, J. (2022). Identifying hub genes, key pathways and key immune-related genes in Peyronie\u2019s disease by integrated bioinformatic analysis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1019358"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jacbts.2022.01.004","article-title":"Cardiac mesenchymal stem cells promote fibrosis and remodeling in heart failure: Role of PDGF signaling","volume":"7","author":"Hamid","year":"2022","journal-title":"JACC Basic. Transl. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.biocel.2008.05.012","article-title":"A new mouse model of Peyronie\u2019s disease: An increased expression of hypoxia-inducible factor-1 target genes during the development of penile changes","volume":"40","author":"Lucattelli","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Layton, T.B., Williams, L., Yang, N., Zhang, M., Lee, C., Feldmann, M., Trujillo, G., Furniss, D., and Nanchahal, J. (2022). A vasculature niche orchestrates stromal cell phenotype through PDGF signaling: Importance in human fibrotic disease. Proc. Natl. Acad. Sci. USA, 119.","DOI":"10.1073\/pnas.2120336119"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/path.4814","article-title":"Fine-tuning vascular fate during endothelial-mesenchymal transition","volume":"241","author":"Xiao","year":"2017","journal-title":"J. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s13555-020-00407-6","article-title":"The Japanese experience with basic fibroblast growth factor in cutaneous wound management and scar prevention: A systematic review of clinical and biological Aspects","volume":"10","author":"Abdelhakim","year":"2020","journal-title":"Dermatol. Ther. (Heidelb.)"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00005392-200102000-00016","article-title":"Basic fibroblast growth factor expression in Peyronie\u2019s disease. Basic fibroblast growth factor expression in Peyronie\u2019s disease","volume":"165","author":"Mulhall","year":"2001","journal-title":"J. Urol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Burks, T.N., and Cohn, R.D. (2011). Role of TGF-\u03b2 signaling in inherited and acquired myopathies. Skelet. Muscle, 1.","DOI":"10.1186\/2044-5040-1-19"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.hlc.2017.05.138","article-title":"Absence of myostatin improves cardiac function following myocardial infarction","volume":"27","author":"Lim","year":"2018","journal-title":"Heart Lung Circ."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.1743-6109.2008.00847.x","article-title":"Profibrotic role of myostatin in Peyronie\u2019s disease","volume":"5","author":"Cantini","year":"2008","journal-title":"J. Sex. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajpath.2018.09.007","article-title":"AP39, a modulator of mitochondrial bioenergetics, reduces antiangiogenic response and oxidative stress in hypoxia-exposed trophoblasts: Relevance for preeclampsia pathogenesis","volume":"189","author":"Covarrubias","year":"2019","journal-title":"Am. J. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Li, X., Xing, J., Wang, H., and Yu, E. (2019). The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer. Biosci. Rep., 39.","DOI":"10.1042\/BSR20180268"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Kim, J., Kim, B., Kim, S.M., Yang, C.E., Song, S.Y., Lee, W.J., and Lee, J.H. (2019). Hypoxia-induced epithelial-to-mesenchymal transition mediates fibroblast abnormalities via ERK activation in cutaneous wound healing. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102546"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Cui, Y., Wang, Y., Men, C., Wu, J., and Liu, L. (2022). Bioinformatics-based identification of potential hypoxia-related genes associated with Peyronie\u2019s disease. Am. J. Mens Health, 16.","DOI":"10.1177\/15579883221111720"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.matbio.2015.06.003","article-title":"The extracellular matrix: Tools and insights for the \u201comics\u201d era","volume":"49","author":"Naba","year":"2016","journal-title":"Matrix. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Randles, M., and Lennon, R. (2015). Applying proteomics to investigate extracellular matrix in health and disease. Curr. Top. Membr., 76.","DOI":"10.1016\/bs.ctm.2015.06.001"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Paulis, G., De Giorgio, G., and Paulis, L. (2022). Role of oxidative stress in Peyronie\u2019s disease: Biochemical evidence and experiences of treatment with antioxidants. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415969"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.juro.2008.01.093","article-title":"Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1beta and transforming growth factor-beta in Peyronie\u2019s plaque fibroblasts","volume":"179","author":"Cole","year":"2008","journal-title":"J. Urol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jare.2017.06.004","article-title":"Extracellular matrix alterations in the Peyronie\u2019s disease","volume":"8","author":"Watanabe","year":"2017","journal-title":"J. Adv. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0036-1586228","article-title":"The role of plasminogen activator inhibitor type-1 in fibrosis","volume":"43","author":"Flevaris","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.urology.2005.01.010","article-title":"Peyronie\u2019s disease associated with increase in plasminogen activator inhibitor in fibrotic plaque","volume":"65","author":"Davila","year":"2005","journal-title":"Urology"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Micallef, L., Vedrenne, N., Billet, F., Coulomb, B., Darby, I.A., and Desmouli\u00e8re, A. (2012). The myofibroblast, multiple origins for major roles in normal and pathological tissue repair. Fibrogenesis Tissue Repair, 5.","DOI":"10.1186\/1755-1536-5-S1-S5"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-394307-1.00003-5","article-title":"Hypoxia and hypoxia signaling in tissue repair and fibrosis","volume":"296","author":"Lokmic","year":"2012","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00345-008-0320-x","article-title":"Upregulation of mRNA expression of MCP-1 by TGF-beta1 in fibroblast cells from Peyronie\u2019s disease","volume":"27","author":"Konrad","year":"2009","journal-title":"World. J. Urol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","article-title":"EAU guidelines on penile curvature","volume":"62","author":"Hatzimouratidis","year":"2012","journal-title":"Eur. Urol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Hao, M., Han, X., Yao, Z., Zhang, H., Zhao, M., Peng, M., Wang, K., Shan, Q., Sang, X., and Wu, X. (2022). The pathogenesis of organ fibrosis: Focus on necroptosis. Br. J. Pharmacol.","DOI":"10.22541\/au.165045626.68467796\/v1"},{"key":"ref_94","first-page":"607","article-title":"Comparison of apoptotic gene expression profiles between Peyronie\u2019s disease plaque and tunica albuginea","volume":"21","author":"Zorba","year":"2012","journal-title":"Clin. Exp. Med."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Loreto, C., La Rocca, G., Anzalone, R., Caltabiano, R., Vespasiani, G., Castorina, S., Ralph, D.J., Cellek, S., Musumeci, G., and Giunta, S. (2014). The role of intrinsic pathway in apoptosis activation and progression in Peyronie\u2019s disease. Biomed. Res. Int.","DOI":"10.1155\/2014\/616149"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1743-6109.2010.02003.x","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its death receptor (DR5) in Peyronie\u2019s disease. A biomolecular study of apoptosis activation","volume":"8","author":"Loreto","year":"2011","journal-title":"J. Sex. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","article-title":"Evasion of apoptosis by myofibroblasts: A hallmark of fibrotic diseases. Evasion of apoptosis by myofibroblasts: A hallmark of fibrotic diseases","volume":"16","author":"Hinz","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/ijcp.12129","article-title":"Understanding the course of Peyronie\u2019s disease","volume":"67","author":"Garaffa","year":"2013","journal-title":"Int. J. Clin. Pract."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.euf.2021.04.012","article-title":"Single-cell transcriptomics uncover a novel role of myeloid cells and T-lymphocytes in the fibrotic microenvironment in Peyronie\u2019s disease","volume":"8","author":"Milenkovic","year":"2022","journal-title":"Eur. Urol. Focus"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-021-00646-w","article-title":"Transforming growth factor-\u03b2 in myocardial disease","volume":"19","author":"Frangogiannis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Gundogdu, G., Nguyen, T., Namasivayam, A., Starek, S., Gelman, J., and Mauney, J.R. (2023). Characterization of a novel rabbit model of Peyronie\u2019s disease. Int. J. Impot. Res.","DOI":"10.1038\/s41443-023-00671-y"},{"key":"ref_102","first-page":"446","article-title":"Animal models of Peyronie\u2019s disease: An update","volume":"22","author":"Li","year":"2016","journal-title":"Zhonghua Nan Ke Xue"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/art.39865","article-title":"Review: Frontiers of antifibrotic therapy in systemic sclerosis","volume":"69","author":"Distler","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000242477","article-title":"Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes","volume":"30","author":"Seo","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00210-020-01826-0","article-title":"Serotonin 5HT2A receptor antagonism mediated anti-inflammatory and anti-fibrotic effect in adriamycin-induced CKD in rats","volume":"393","author":"Chaturvedi","year":"2020","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/1756-185X.13386","article-title":"5-HT2 and 5-HT2B antagonists attenuate pro-fibrotic phenotype in human adult dermal fibroblasts by blocking TGF-\u03b21 induced non-canonical signaling pathways including STAT3: Implications for fibrotic diseases like scleroderma","volume":"21","author":"Chaturvedi","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Shi, X., Yang, J., Deng, S., Xu, H., Wu, D., Zeng, Q., Wang, S., Hu, T., Wu, F., and Zhou, H. (2022). TGF-\u03b2 signaling in the tumor metabolic microenvironment and targeted therapies. J. Hematol. Oncol., 15.","DOI":"10.1186\/s13045-022-01349-6"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature10152","article-title":"Latent TGF-\u03b2 structure and activation","volume":"474","author":"Shi","year":"2011","journal-title":"Nature"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00441-016-2407-9","article-title":"\u03b1v integrins: Key regulators of tissue fibrosis","volume":"365","author":"Conroy","year":"2016","journal-title":"Cell Tissue Res."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Xu, L., Zhang, Y., Chen, J., and Xu, Y.J. (2020). Thrombospondin-1: A key protein that induces fibrosis in diabetic complications. Diabetes Res., 2020.","DOI":"10.1155\/2020\/8043135"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Yi, W., Chen, F., Zhang, H., Tang, P., Yuan, M., Wen, J., Wang, S., and Cai, Z. (2022). Role of angiotensin II in aging. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.1002138"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.juro.2009.01.097","article-title":"Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats","volume":"181","author":"Canguven","year":"2009","journal-title":"J. Urol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.mehy.2011.11.008","article-title":"Drugs of the future for Peyronie\u2019s disease","volume":"78","author":"Gur","year":"2012","journal-title":"Med. Hypotheses"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jsxm.2020.08.008","article-title":"Characterization of the renin-angiotensin system in aged cavernosal tissue and its role in penile fibrosis","volume":"17","author":"Bragina","year":"2020","journal-title":"J. Sex. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.eururo.2006.05.002","article-title":"Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie\u2019s disease","volume":"51","author":"Haag","year":"2007","journal-title":"Eur. Urol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/10409238.2020.1828260","article-title":"Current perspectives on inhibitory SMAD7 in health and disease. Current perspectives on inhibitory SMAD7 in health and disease","volume":"55","author":"Spit","year":"2020","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4103\/1008-682X.142130","article-title":"Effect of SMAD7 gene overexpression on TGF-\u03b21-induced profibrotic responses in fibroblasts derived from Peyronie\u2019s plaque","volume":"17","author":"Choi","year":"2015","journal-title":"Asian J. Androl."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Wang, W., Ding, W., Zhang, X., Wu, S., Yu, T., Cui, X., Xie, Y., Yang, D., and Lin, C. (2022). Intratunical injection of rat-derived bone marrow mesenchymal stem cells prevents fibrosis and is associated with increased Smad7 expression in a rat model of Peyronie\u2019s disease. Stem. Cell. Res. Ther., 13.","DOI":"10.1186\/s13287-022-03090-w"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1681\/ASN.2003100905","article-title":"Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA","volume":"16","author":"Wahab","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Yu, X.Y., Sun, Q., Zhang, Y.M., Zou, L., and Zhao, Y.Y. (2022). TGF-\u03b2\/Smad Signaling Pathway in Tubulointerstitial Fibrosis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.860588"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1464-410X.2011.10733.x","article-title":"Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie\u2019s disease: A phase I study","volume":"110","author":"Pavone","year":"2012","journal-title":"BJU Int."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Sarenac, T., Trapecar, M., Gradisnik, L., Rupnik, M.S., and Pahor, D. (2016). Single-cell analysis reveals IGF-1 potentiation of inhibition of the TGF-\u03b2\/Smad pathway of fibrosis in human keratocytes in vitro. Sci. Rep., 6.","DOI":"10.1038\/srep34373"},{"key":"ref_123","first-page":"251","article-title":"Alternative splicing of IGF1 gene as a potential factor in the pathogenesis of Peyronie\u2019s disease","volume":"30","author":"Thomas","year":"2016","journal-title":"In Vivo"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/hmg\/ddw090","article-title":"ERK1\/2 directly acts on CTGF\/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A\/C gene","volume":"25","author":"Chatzifrangkeskou","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Grynberg, K., Ma, F.Y., and Nikolic-Paterson, D.J. (2017). The JNK signaling pathway in renal fibrosis. Front. Physiol., 8.","DOI":"10.3389\/fphys.2017.00829"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Liu, N., Feng, J., Lu, X., Yao, Z., Liu, Q., Lv, Y., Han, Y., Deng, J., and Zhou, Y. (2019). Isorhamnetin inhibits liver fibrosis by reducing autophagy and inhibiting extracellular matrix formation via the TGF-\u03b21\/Smad3 and TGF-\u03b21\/p38 MAPK pathways. Mediat. Inflamm., 2019.","DOI":"10.1155\/2019\/6175091"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/jsm.12134","article-title":"Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: Possible involvement of p38 MAPK activation","volume":"10","author":"Toque","year":"2013","journal-title":"J. Sex. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/aja.aja_10_17","article-title":"Role of Jun amino-terminal kinase (JNK) in apoptosis of cavernosal tissue during acute phase after cavernosal nerve injury","volume":"20","author":"Song","year":"2018","journal-title":"Asian J. Androl."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/thoraxjnl-2015-207429","article-title":"Exploration of a potent PI3 kinase\/mTOR inhibitor as a novel anti-fibrotic agent in IPF","volume":"71","author":"Mercer","year":"2016","journal-title":"Thorax"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Tang, Q., Markby, G.R., MacNair, A.J., Tang, K., Tkacz, M., Parys, M., Phadwal, K., MacRae, V.E., and Corcoran, B.M. (2023). TGF-\u03b2-induced PI3K\/AKT\/mTOR pathway controls myofibroblast differentiation and secretory phenotype of valvular interstitial cells through the modulation of cellular senescence in a naturally occurring in vitro canine model of myxomatous mitral valve disease. Cell Prolif.","DOI":"10.1111\/cpr.13435"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm.3777","article-title":"Orphan nuclear receptor NR4A1 regulates transforming growth factor-\u03b2 signaling and fibrosis","volume":"21","author":"Zerr","year":"2015","journal-title":"Nat. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3892\/ijo.2013.1905","article-title":"A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie\u2019s plaques","volume":"42","author":"Jung","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_133","first-page":"960","article-title":"Targeting the Wnt signaling pathway in liver fibrosis for rug options: An update","volume":"9","author":"Duspara","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"186","DOI":"10.21037\/jtd-22-886","article-title":"Molecular mechanisms of alveolar epithelial cell senescence and idiopathic pulmonary fibrosis: A narrative review","volume":"15","author":"Tu","year":"2023","journal-title":"J. Thorac. Dis."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Hu, L., Ding, M., and He, W. (2022). Emerging therapeutic strategies for attenuating tubular EMT and kidney fibrosis by targeting Wnt\/\u03b2-catenin signaling. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.830340"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1743-6109.2009.01556.x","article-title":"Protein biomarker analysis of primary Peyronie\u2019s disease cells","volume":"7","author":"Bella","year":"2010","journal-title":"J. Sex. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1080\/13685538.2019.1643311","article-title":"Glimpses into the molecular pathogenesis of Peyronie\u2019s disease","volume":"23","author":"Werker","year":"2020","journal-title":"Aging Male"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2340\/00015555-0101","article-title":"Upregulation of the Wnt\/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids","volume":"86","author":"Sato","year":"2006","journal-title":"Acta Derm. Venereol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/ATVBAHA.110.220061","article-title":"\u03b2-catenin mediates mechanically regulated, transforming growth factor-\u03b21induced myofibroblast differentiation of aortic valve interstitial cells","volume":"31","author":"Chen","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., and Zwerina, J. (2012). Activation of canonical Wnt signalling is required for TGF-\u03b2-mediated fibrosis. Nat. Commun., 3.","DOI":"10.1038\/ncomms1734"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/annrheumdis-2016-209698","article-title":"The transcription factor GLI2 as a downstream mediator of transforming growth factor-\u03b2-induced fibroblast activation in SSc","volume":"76","author":"Liang","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1165\/rcmb.2014-0108OC","article-title":"Reemergence of hedgehog mediates epithelial-mesenchymal crosstalk in pulmonary fibrosis","volume":"52","author":"Hu","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1111\/bph.13611","article-title":"Forskolin, a hedgehog signalling inhibitor, attenuates carbon tetrachloride-induced liver fibrosis in rats","volume":"173","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1002\/art.34444","article-title":"Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis","volume":"64","author":"Horn","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/mol.114.095141","article-title":"An overview of hedgehog signaling in fibrosis","volume":"87","author":"Hu","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Petzold, J., and Gentleman, E. (2021). Intrinsic mechanical cues and their impact on stem cells and embryogenesis. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.761871"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Mia, M.M., and Singh, M.K. (2022). New insights into Hippo\/YAP signaling in fbrotic diseases. Cells, 11.","DOI":"10.3390\/cells11132065"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1053\/j.gastro.2018.02.015","article-title":"P300 acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts","volume":"154","author":"Dou","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.urology.2004.04.006","article-title":"Comparison of gene expression profiles between Peyronie\u2019s disease and Dupuytren\u2019s contracture","volume":"64","author":"Qian","year":"2004","journal-title":"Urology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/bju.14638","article-title":"Simvastatin and the Rho-kinase inhibitor Y-27632 prevent myofibroblast transformation in Peyronie\u2019s disease-derived fibroblasts via inhibition of YAP\/TAZ nuclear translocation","volume":"123","author":"Milenkovic","year":"2019","journal-title":"BJU Int."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Kim, C.L., Choi, S.H., and Mo, J.S. (2019). Role of the Hippo pathway in fibrosis and cancer. Cells, 8.","DOI":"10.3390\/cells8050468"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Petrouj, I.G., Nikou, S., Madduri, S., Nifora, M., Bravou, V., and Kalbermatten, D.F. (2022). The role of Hippo signaling pathway and ILK in the pathophysiology of human hypertrophic scars and keloids: An immunohistochemical investigation. Cells, 11.","DOI":"10.3390\/cells11213426"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1439-0272.2012.01313.x","article-title":"Effects of integrin-linked kinase on human corpus cavernosum smooth muscle cell cytoskeletal organisation","volume":"45","author":"Hao","year":"2013","journal-title":"Andrologia"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Nakamura, R., Hiwatashi, N., Bing, R., Doyle, C.P., and Branski, R.C. (2021). Concurrent YAP\/TAZ and SMAD signaling mediate vocal fold fibrosis. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-92871-z"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3892\/ijmm.2015.2288","article-title":"Estradiol attenuates the TGF-\u03b21-induced conversion of primary TAFs into myofibroblasts and inhibits collagen production and myofibroblast contraction by modulating the Smad and Rho\/ROCK signaling pathways","volume":"36","author":"Jiang","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Boyd, R.J., Avramopoulos, D., Jantzie, L.L., and McCallion, A.S. (2022). Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases. Neuroinflammation, 19.","DOI":"10.1186\/s12974-022-02584-x"},{"key":"ref_157","first-page":"211","article-title":"Genetic architecture of common multifactorial diseases","volume":"197","author":"Sing","year":"1996","journal-title":"Ciba. Found Symp."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0022-5347(17)44170-X","article-title":"Chromosome abnormalities in Peyronie\u2019s disease","volume":"137","author":"Somers","year":"1987","journal-title":"J. Urol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.ijir.3901170","article-title":"Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie\u2019s disease","volume":"16","author":"Mulhall","year":"2004","journal-title":"Int. J. Impot. Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-5347(05)64129-8","article-title":"Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie\u2019s disease","volume":"169","author":"Hauck","year":"2003","journal-title":"J. Urol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/j.1743-6109.2012.02704.x","article-title":"WNT2 locus is involved in genetic susceptibility of Peyronie\u2019s disease","volume":"9","author":"Dolmans","year":"2012","journal-title":"J. Sex. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.urology.2022.02.023","article-title":"Whole-genome sequencing identifies novel heterozygous mutation in ALMS1 in three men with both Peyronie\u2019s and Dupuytren\u2019s disease","volume":"166","author":"Dullea","year":"2022","journal-title":"Urology"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez-Satta, M., Lago-Docampo, M., Bea-Mascato, B., Solarat, C., Castro-S\u00e1nchez, S., Christensen, S.T., and Valverde, D. (2021). ALMS1 regulates TGF-\u03b2 signaling and morphology of primary cilia. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.623829"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Bea-Mascato, B., Neira-Goyanes, E., Iglesias-Rodr\u00edguez, A., and Valverde, D. (2022). Depletion of ALMS1 affects TGF-\u03b2 signalling pathway and downstream processes such as cell migration and adhesion capacity. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.992313"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Jones, D.L., Haak, A.J., Caporarello, N., Choi, K.M., Ye, Z., Yan, H., Varelas, X., Ordog, T., Ligresti, G., and Tschumperlin, D.J. (2019). TGF\u03b2-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression. J. Cell. Sci., 132.","DOI":"10.1242\/jcs.233486"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5534\/wjmh.170005","article-title":"Silencing histone deacetylase 7 alleviates transforming growth factor-\u03b21-induced profibrotic responses in fibroblasts derived from Peyronie\u2019s plaque","volume":"36","author":"Kang","year":"2018","journal-title":"World. J. Mens Health"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Wang, M., Huo, Z., Wu, L., Liu, F., Liang, J., He, X., and Yang, D. (2023). The role of miR-29 in the mechanism of fibrosis. Mini. Rev. Med. Chem.","DOI":"10.2174\/1389557523666230328125031"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/03915603211036628","article-title":"Downregulation of miR-29b is associated with Peyronie\u2019s disease","volume":"89","author":"Neto","year":"2022","journal-title":"Urologia"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.eururo.2004.04.028","article-title":"Alpha-1-antitrypsin levels and genetic variation of the alpha-1-antitrypsin gene in Peyronie\u2019s disease","volume":"46","author":"Hauck","year":"2004","journal-title":"Eur. Urol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie\u2019s disease: Results of a large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1023\/A:1014485204205","article-title":"Peyronie\u2019s disease: Epidemiology and clinical presentation of 134 cases","volume":"32","author":"Perimenis","year":"2001","journal-title":"Int. Urol. Nephrol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1743-6109.2009.01250.x","article-title":"Testosterone deficiency and Peyronie\u2019s disease: Pilot data suggesting a significant relationship","volume":"6","author":"Moreno","year":"2009","journal-title":"J. Sex. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1442-2042.2011.02842.x","article-title":"Does testosterone deficiency exaggerate the clinical symptoms of Peyronie\u2019s disease?","volume":"18","author":"Nam","year":"2011","journal-title":"Int. J. Urol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2164\/jandrol.111.012948","article-title":"Association between Peyronie disease and low serum testosterone levels: Detection and therapeutic considerations","volume":"33","author":"Cavallini","year":"2012","journal-title":"J. Androl."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/iju.15055","article-title":"Significant inverse association of testosterone level with penile deformity severity in Japanese males with Peyronie\u2019s disease","volume":"30","author":"Mitsui","year":"2023","journal-title":"Int. J. Urol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1038\/onc.2013.374","article-title":"Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer","volume":"33","author":"Mishra","year":"2014","journal-title":"Oncogene"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5534\/wjmh.210126","article-title":"ABO blood type and risk of Peyronie\u2019s disease in Japanese males","volume":"40","author":"Mitsui","year":"2022","journal-title":"World J. Mens Health"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1086\/315375","article-title":"Increased inflammatory responses of persons of blood group O to Helicobacter pylori","volume":"181","author":"Alkout","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ng.601","article-title":"A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci","volume":"42","author":"Bei","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Liu, W.C., Chuang, H.C., Chou, C.L., Lee, Y.H., Chiu, Y.J., Wang, Y.L., and Chiu, H.W. (2022). Cigarette smoke exposure increases glucose-6-phosphate dehydrogenase, autophagy, fibrosis, and senescence in kidney cells in vitro and in vivo. Oxid. Med. Cell. Longev., 2022.","DOI":"10.1155\/2022\/5696686"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1158\/1535-7163.MCT-12-0107","article-title":"Smoking induces epithelial-to-mesenchymal transition in non-small cell lung cancer through HDAC-mediated downregulation of E-cadherin","volume":"11","author":"Nagathihalli","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Wu, Y., Song, P., Yuan, X., and Li, D. (2021). Exploring the effect of dapagliflozin on alcoholic kidney injury and renal interstitial fibrosis in rats based on TIMP-1\/MMP-24 pathway. Evid. Based Complement. Alternat. Med., 2021.","DOI":"10.1155\/2021\/6538189"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Zdanowicz, K., Kowalczuk-Kryston, M., Olanski, W., Werpachowska, I., Mielech, W., and Lebensztejn, D.M. (2022). Increase in serum MMP-9 and TIMP-1 concentrations during alcohol intoxication in adolescents-a preliminary study. Biomolecules, 12.","DOI":"10.3390\/biom12050710"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Paulis, G., Paulis, A., and Perletti, G.A. (2023). Congenital penile curvature as a possible risk factor for the onset of Peyronie\u2019s disease, and psychological consequences of penile curvature. Arch. Ital. Urol. Androl., 95.","DOI":"10.4081\/aiua.2023.11238"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajmg.1320120213","article-title":"Peyronie\u2019s disease: A newly recognized autosomal-dominant trait","volume":"12","author":"Bias","year":"1982","journal-title":"Am. J. Med. Genet."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Dedeoglu, S., Dede, E., Oztunc, F., Gedikbasi, A., Yesil, G., and Dedeoglu, R. (2022). Mutation identification and prediction for severe cardiomyopathy in Alstr\u00f6m syndrome, and review of the literature for cardiomyopathy. Orphanet. J. Rare Dis., 17.","DOI":"10.1186\/s13023-022-02483-7"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Zulato, E., Favaretto, F., Veronese, C., Campanaro, S., Marshall, J.D., Romano, S., Cabrelle, A., Collin, G.B., Zavan, B., and Belloni, A.S. (2011). ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019081"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/annrheumdis-2014-205303","article-title":"Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies","volume":"74","author":"Altorok","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00345-019-02815-6","article-title":"A review of inflammation and fibrosis: Implications for the pathogenesis of Peyronie\u2019s disease","volume":"38","author":"Patel","year":"2020","journal-title":"World J. Urol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: An expanding universe","volume":"186","author":"Blasco","year":"2023","journal-title":"Cell"},{"key":"ref_191","first-page":"33","article-title":"Effect of androgen deprivation on penile ultrastructure","volume":"5","author":"Shen","year":"2003","journal-title":"Asian J. Androl."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1111\/j.1743-6109.2010.01915.x","article-title":"The relationship between androgens, regulators of collagen metabolism, and Peyronie\u2019s disease: A case control study","volume":"7","author":"Karavitakis","year":"2010","journal-title":"J. Sex. Med."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/jsm.12805","article-title":"Low testosterone has a similar prevalence among men with sexual dysfunction due to either Peyronie\u2019s disease or erectile dysfunction and does not correlate with Peyronie\u2019s disease severity","volume":"12","author":"Kirby","year":"2015","journal-title":"J. Sex. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jsxm.2019.05.021","article-title":"Testosterone levels are not associated with magnitude of deformity in men with Peyronie\u2019s disease","volume":"16","author":"Mulhall","year":"2019","journal-title":"J. Sex. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41443-020-0340-7","article-title":"Serum testosterone levels are not associated with the severity of penile curvature in men with Peyronie\u2019s disease-findings from a cross-sectional study","volume":"33","author":"Candela","year":"2020","journal-title":"Int. J. Impot. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/15513815.2022.2104496","article-title":"Quantification of the androgen and estrogen receptors in the penile tissues of hypospadias in comparison with normal children","volume":"42","author":"Khanna","year":"2023","journal-title":"Fetal. Pediatr. Pathol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1464-410X.2006.05969.x","article-title":"Risk factors for Peyronie\u2019s disease: A case-control study","volume":"97","author":"Bjekic","year":"2006","journal-title":"BJU Int."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1159\/000049830","article-title":"Peyronie\u2019s disease: Prevalence and association with cigarette smoking. a multicenter population-based study in men aged 50\u201369 years","volume":"40","author":"Pescatori","year":"2001","journal-title":"Eur. Urol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.eururo.2005.10.026","article-title":"Prevalence of Peyronie\u2019s disease among patients with erectile dysfunction","volume":"49","year":"2006","journal-title":"Eur. Urol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.5476","article-title":"The systemic influence of chronic smoking on skin structure and mechanical function","volume":"251","author":"Langton","year":"2020","journal-title":"J. Pathol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1464-410X.1982.tb13640.x","article-title":"Factors associated in the aetiology of peyronie\u2019s disease","volume":"54","author":"Chilton","year":"1982","journal-title":"Br. J. Urol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12199-011-0235-9","article-title":"Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5\/Dmcr","volume":"17","author":"Kitamori","year":"2012","journal-title":"Environ. Health. Prev. Med."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Yuan, Y., Naito, H., Jia, X., Kitamori, K., and Nakajima, T. (2017). Combination of hypertension along with a high fat and cholesterol diet induces severe hepatic inflammation in rats via a signaling network comprising NF-\u03baB, MAPK, and Nrf2 pathways. Nutrients, 9.","DOI":"10.20944\/preprints201707.0033.v1"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.1073\/pnas.1809872115","article-title":"Genetic variation in the SIM1 locus is associated with erectile dysfunction","volume":"115","author":"Jorgenson","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajhg.2018.11.004","article-title":"GWAS identifies risk locus for erectile dysfunction and implicates hypothalamic neurobiology and diabetes in etiology","volume":"104","author":"Bovijn","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.euf.2019.08.006","article-title":"Erectile dysfunction and Peyronie\u2019s disease: Genetic diseases?","volume":"6","author":"Patel","year":"2020","journal-title":"Eur. Urol. Focus"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1142\/S2424835521500235","article-title":"Epidemiology of Dupuytren\u2019s disease in Japanese general population","volume":"26","author":"Sasaki","year":"2021","journal-title":"J. Hand. Surg. Asian Pac. Vol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1101029","article-title":"Wnt signaling and Dupuytren\u2019s disease","volume":"365","author":"Dolmans","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12079-015-0312-8","article-title":"Further evidence of the involvement of the Wnt signaling pathway in Dupuytren\u2019s disease","volume":"10","author":"Bank","year":"2016","journal-title":"J. Cell Commun. Signal."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ajhg.2017.08.006","article-title":"A genome-wide association study of Dupuytren Disease reveals 17 additional variants implicated in fibrosis","volume":"101","author":"Ng","year":"2017","journal-title":"Am. J. Hum. Genet."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/12\/10133\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:54:59Z","timestamp":1760126099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/12\/10133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":210,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["ijms241210133"],"URL":"https:\/\/doi.org\/10.3390\/ijms241210133","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]}}}